Background: Rates of new HIV infection in men who have sex with men (MSM) have in the UK and elsewhere increased in recent years, despite high levels of ART coverage and the majority of people on ART having a suppressed viral load to very low levels. It has been suggested that the beneficial effects of ART on HIV transmission have likely been counter-acted by a small but significant increase in overall levels of condom-less sex in MSM in general. A further factor which needs to be considered is that a high proportion of new infections probably arise from people undiagnosed with HIV, many of whom are in primary infection. Clearly, one challenge for realization of the maximum benefits of ART in preventing transmission is to be able to diagnose people sufficiently early after infection, and ideally while in the acute stage of infection. It is not intuitively clear how high rates of HIV diagnosis and ART coverage, and how limited any increases in condom-less sex need to be, in order to bring down rates of new infections to a very low level. The talk will mainly consist of presentation of insights into these questions from the UK MSM HIV Synthesis model, an individual-based simulation model of the epidemic in MSM in UK. The fit of the model to the UK epidemic is informed by data on sexual behaviour, HIV testing, HIV diagnoses, AIDS, death, CD4 count at diagnosis, recent infection at diagnosis, viral load and CD4 count profile of treated people, and levels of drug resistance. The model was used to reconstruct the epidemic in order to study the potential effects of future increases in HIV testing, changes in eligibility criteria for ART initiation, and changes in overall levels of condom-less sex. These results will be compared to those obtained from other MSM epidemics. Areas of uncertainty in model parameters for which additional information is required will be highlighted. These include the individual health benefits of very early ART initiation, changes in levels of condom-less sex induced by HIV diagnosis, and the effect of ART-induced viral suppression on reducing transmission through anal sex. Conclusions: Antiretroviral treatment and condom use are both exerting a substantial limiting effect on the HIV epidemic in MSM in the UK and elsewhere and we should seek appropriate ways to maximise these effects. In particular, it is critical that the importance of condom use is continuously emphasized as a key element of prevention, with information made widely available on the specific circumstances in which risk of transmission of HIV and other infections is sufficiently low to consider lack of condom use.